user

Age as a predictive factor of disease activity after discontinuation of Disease Modifying Treatment in Multiple Sclerosis

被引：0
|
作者：
Soares, Mafalda Delgado [1 ,2 ]
Faustino, Patricia [1 ,2 ]
Sequeira, Joao [2 ]
Marques, Jose Pinto [2 ]
Sousa, Ana [2 ]
Grine, Teresa [2 ]
Mateus, Claudia [2 ]
Encarnacao, Susana [2 ]
Santos, Ana Catarina [2 ]
Gama, Anabela [2 ]
Capela, Carlos [2 ]
Ladeira, Filipa [2 ]
机构：
[1] Ctr Hosp Univ Lisboa Cent, Neurol, Dept Lisbon, Lisbon, Portugal
[2] Ctr Hosp Univ Lisboa Cent, Multiple Sclerosis Ctr Integrated Responsabil, Lisbon, Portugal
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1521/1363
引用
收藏
页码：970 / 971
页数：2
相关论文
共 50 条
  • [1] Disease Modifying Therapy Discontinuation in Patients with Multiple Sclerosis Over Age 60
    Hua, Le H.
    Fan, Huijun
    Conway, Devon
    Kinzy, Tyler G.
    Thompson, Nicolas
    NEUROLOGY, 2017, 88
  • [2] The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis
    Coerver, Eline
    Schoof, Lisa
    Hogenboom, Laura
    Wessels, Mark
    van Ruyven, Paula
    van Samkar, Anusha
    Mostert, Jop
    van Kempen, Zoe
    van Oosten, Bob
    Wokke, Beatrijs
    Tallantyre, Emma
    Myhr, Kjell-Morten
    Torkildsen, Oivind
    Killestein, Joep
    Smets, Ide
    Strijbis, Eva
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1063 - 1064
  • [3] The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis
    Coerver, E.
    Schoof, L.
    Hogenboom, L.
    Wessels, M.
    van Ruyven, P.
    van Samkar, A.
    Mostert, J.
    van Kempen, Z.
    van Oosten, B. W.
    Wokke, B. H.
    Tallantyre, E.
    Myhr, K. M.
    Torkildsen, O.
    Killestein, J.
    Smets, I.
    Strijbis, E.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 91
  • [4] Discontinuation of disease-modifying therapy in patients with multiple sclerosis over age 60
    Hua, Le H.
    Fan, Tracey H.
    Conway, Devon
    Thompson, Nicolas
    Kinzy, Tyler G.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (05) : 699 - 708
  • [5] Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosis
    Pasca, Matteo
    Forci, Benedetta
    Mariottini, Alice
    Mechi, Claudia
    Barilaro, Alessandro
    Massacesi, Luca
    Repice, Anna Maria
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 47
  • [6] Disease modifying treatment in multiple sclerosis
    Fuller, GN
    Bone, I
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 71 : II20 - II21
  • [7] Disease activity after natalizumab discontinuation in multiple sclerosis: reactivation or rebound?
    Borriello, G.
    Prosperini, L.
    Mancinelli, C.
    Fubelli, F.
    Gianni, C.
    Marinelli, F.
    Pozzilli, C.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S228 - S228
  • [8] Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation
    Martinelli, Vittorio
    Dalla Costa, Gloria
    Sangalli, Francesca
    Colombo, Bruno
    Robotti, Micaela
    Moiola, Lucia
    Comi, Giancarlo
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 28 : 57 - 59
  • [9] Disease activity after discontinuation of disease-modifying therapies in patients with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM
    Zanga, G.
    Portinari, C.
    Barber, J.
    Brolese, L.
    Pappolla, A.
    Miguez, J.
    Patrucco, L.
    Cristiano, E.
    Deri, N.
    Tkachuk, V.
    Vrech, C.
    Cohen, L.
    Alonso, R.
    Garcea, O.
    Silva, B.
    Ysrraelit, C.
    Marrodan, M.
    Gaitan, M. I.
    Correale, J.
    Burgos, M.
    Lazaro, L.
    Chertcoff, A.
    Silva, E.
    Knorre, E.
    Steinberg, J.
    Tavolini, D.
    Hryb, J.
    Nofal, P.
    Leguizamon, F.
    Lopez, P. A.
    Liwacki, S.
    Luetic, G.
    Blaya, P.
    Piedrabuena, R.
    Carra, A.
    Martinez, A.
    Balbuena, M. E.
    Carnero Contentti, E.
    Alves Pinheiro, A.
    Mainella, C.
    Coppola, M.
    Recchia, L.
    Kohler, M.
    Pagani, F.
    Menichini, M. L.
    Tizio, S.
    Barboza, A.
    Ibanez, T.
    Rojas, J. I.
    Sorbara, M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 582 - 583
  • [10] Disease activity after discontinuation of disease-modifying therapies in patients with multiple sclerosis in Argentina: data from the nationwide registry RelevarEM
    Gisela, Zanga
    Carla, Portinari
    Josefina, Barber
    Tomas, Ibanez
    Lucia, Brolese
    Pappolla, Agustin
    Miguez, Jimena
    Patrucco, Liliana
    Cristiano, Edgardo
    Norma, Deri
    Veronica, Tkachuk
    Carlos, Vrech
    Leila, Cohen
    Alonso, Ricardo
    Garcea, Orlando
    Silva, Berenice
    Celica, Ysrraelit
    Marrodan, Mariano
    Gaitan, Maria, I
    Correale, Jorge
    Marcos, Burgos
    Luciana, Lazaro
    Anibal, Chertcoff
    Emanuel, Silva
    Eduardo, Knorre
    Judith, Steinberg
    Dario, Tavolini
    Javier, Hryb
    Pedro, Nofal
    Felisa, Leguizamon
    Pablo, Lopez A.
    Susana, Liwacki
    Patricio, Blaya
    Raul, Piedrabuena
    Adriana, Carra
    Alejandra, Martinez
    Eugenia, Balbuena Maria
    Edgar, Carnero Contentti
    Amelia, Alves Pinheiro
    Carolina, Mainella
    Mariano, Coppola
    Luciano, Recchia
    Matias, Kohler
    Eduardo, Kohler
    Celeste, Curbelo Maria
    Laura, Menichini Maria
    Santiago, Tizio
    Mariela, Cabrera
    Fatima, Pagani Cassara
    Andres, Barboza
    NEUROLOGICAL RESEARCH, 2023, 45 (02) : 112 - 117
12345